Bioequivalence of fixed‐dose combinations of dapagliflozin and metformin with single‐component tablets in healthy subjects and the effect of food on bioavailability

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|5|2|118-130

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.5, Iss.2, 2016-03, pp. : 118-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

By Boulton David W.  

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 619-630

Adis International

Access to resources Recommend Favorite

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite

Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin: Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects

By Hoelscher David  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 573-582

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Comparative Bioavailability of Two Metformin Formulations after Single-Dose Administration in Healthy Subjects

By Atanasova I.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 743-749

Adis International

Access to resources Recommend Favorite

The relative bioavailability of 2 prototype fixed‐dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 131-140

John Wiley & Sons Inc

Access to resources Recommend Favorite